Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Monte Carlo Method | 39 | 2023 | 708 | 4.120 |
Why?
|
| Proton Therapy | 35 | 2023 | 1637 | 3.850 |
Why?
|
| Protons | 20 | 2023 | 480 | 2.790 |
Why?
|
| Radiometry | 23 | 2023 | 1021 | 1.810 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 22 | 2018 | 2459 | 1.750 |
Why?
|
| Particle Accelerators | 17 | 2010 | 362 | 1.320 |
Why?
|
| Photons | 14 | 2019 | 536 | 1.130 |
Why?
|
| Neutrons | 12 | 2010 | 117 | 1.130 |
Why?
|
| Radiotherapy Dosage | 34 | 2022 | 4020 | 0.980 |
Why?
|
| Models, Biological | 13 | 2015 | 3187 | 0.950 |
Why?
|
| Models, Statistical | 12 | 2015 | 1185 | 0.900 |
Why?
|
| Linear Energy Transfer | 5 | 2019 | 108 | 0.850 |
Why?
|
| Radiation Protection | 6 | 2007 | 204 | 0.840 |
Why?
|
| Phantoms, Imaging | 14 | 2023 | 1330 | 0.820 |
Why?
|
| Radiation Monitoring | 4 | 2007 | 53 | 0.820 |
Why?
|
| Scattering, Radiation | 13 | 2015 | 334 | 0.810 |
Why?
|
| Radiotherapy, High-Energy | 10 | 2013 | 303 | 0.810 |
Why?
|
| Computer Simulation | 18 | 2015 | 1569 | 0.780 |
Why?
|
| Software | 6 | 2015 | 1357 | 0.720 |
Why?
|
| Relative Biological Effectiveness | 12 | 2022 | 227 | 0.720 |
Why?
|
| Water | 5 | 2016 | 386 | 0.670 |
Why?
|
| Absorption, Radiation | 2 | 2016 | 10 | 0.660 |
Why?
|
| Helium | 2 | 2022 | 23 | 0.580 |
Why?
|
| Radiotherapy | 4 | 2015 | 1858 | 0.560 |
Why?
|
| Eye | 1 | 2017 | 284 | 0.520 |
Why?
|
| Biomimetic Materials | 1 | 2015 | 39 | 0.510 |
Why?
|
| Radiation Dosage | 12 | 2016 | 1042 | 0.490 |
Why?
|
| Radiotherapy, Conformal | 7 | 2010 | 898 | 0.490 |
Why?
|
| Filtration | 5 | 2007 | 87 | 0.490 |
Why?
|
| Computer-Aided Design | 3 | 2006 | 74 | 0.480 |
Why?
|
| Radiotherapy, Intensity-Modulated | 9 | 2018 | 2178 | 0.480 |
Why?
|
| Algorithms | 13 | 2022 | 3905 | 0.410 |
Why?
|
| Models, Theoretical | 2 | 2013 | 799 | 0.380 |
Why?
|
| Equipment Failure Analysis | 10 | 2013 | 324 | 0.340 |
Why?
|
| Cyclotrons | 2 | 2005 | 10 | 0.310 |
Why?
|
| Uncertainty | 5 | 2017 | 327 | 0.310 |
Why?
|
| Equipment Design | 11 | 2010 | 1206 | 0.290 |
Why?
|
| Prostatic Neoplasms | 8 | 2022 | 5868 | 0.290 |
Why?
|
| Environmental Exposure | 2 | 2010 | 287 | 0.280 |
Why?
|
| Technology, Radiologic | 1 | 2006 | 78 | 0.260 |
Why?
|
| Synchrotrons | 2 | 2022 | 35 | 0.250 |
Why?
|
| Cell Death | 2 | 2019 | 685 | 0.250 |
Why?
|
| Body Burden | 5 | 2016 | 64 | 0.240 |
Why?
|
| Lung | 1 | 2015 | 3287 | 0.230 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2017 | 751 | 0.230 |
Why?
|
| Radioisotopes | 1 | 2005 | 176 | 0.230 |
Why?
|
| Eye Neoplasms | 1 | 2005 | 257 | 0.210 |
Why?
|
| Boron Neutron Capture Therapy | 1 | 2022 | 13 | 0.210 |
Why?
|
| Heavy Ion Radiotherapy | 1 | 2022 | 28 | 0.200 |
Why?
|
| Radiosurgery | 2 | 2009 | 1389 | 0.160 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 92 | 0.160 |
Why?
|
| Homologous Recombination | 1 | 2019 | 188 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2010 | 6765 | 0.140 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2010 | 402 | 0.140 |
Why?
|
| Genes, BRCA1 | 1 | 2019 | 397 | 0.140 |
Why?
|
| Isotopes | 1 | 2016 | 35 | 0.130 |
Why?
|
| Nuclear Medicine | 1 | 2016 | 28 | 0.130 |
Why?
|
| Humans | 36 | 2022 | 270709 | 0.130 |
Why?
|
| Esophagitis | 1 | 2017 | 210 | 0.130 |
Why?
|
| Carbon | 2 | 2022 | 165 | 0.130 |
Why?
|
| Elementary Particles | 1 | 2015 | 24 | 0.130 |
Why?
|
| Radionuclide Imaging | 1 | 2016 | 654 | 0.120 |
Why?
|
| Positron-Emission Tomography | 3 | 2023 | 2199 | 0.120 |
Why?
|
| Ependymoma | 1 | 2016 | 264 | 0.110 |
Why?
|
| Reproducibility of Results | 5 | 2013 | 6192 | 0.110 |
Why?
|
| Esophagus | 1 | 2017 | 562 | 0.110 |
Why?
|
| Software Validation | 3 | 2008 | 30 | 0.110 |
Why?
|
| Absorption | 2 | 2010 | 75 | 0.110 |
Why?
|
| Film Dosimetry | 1 | 2013 | 62 | 0.110 |
Why?
|
| Fiducial Markers | 1 | 2013 | 95 | 0.110 |
Why?
|
| Feasibility Studies | 4 | 2013 | 2360 | 0.090 |
Why?
|
| Aluminum Oxide | 1 | 2010 | 14 | 0.090 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2013 | 340 | 0.090 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 157 | 0.090 |
Why?
|
| Brachytherapy | 1 | 2016 | 1005 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 5157 | 0.080 |
Why?
|
| Finite Element Analysis | 1 | 2008 | 55 | 0.080 |
Why?
|
| Ultrafiltration | 1 | 2007 | 25 | 0.070 |
Why?
|
| Equipment Safety | 1 | 2007 | 64 | 0.070 |
Why?
|
| Femur Head | 1 | 2007 | 42 | 0.070 |
Why?
|
| Uveal Neoplasms | 1 | 2008 | 194 | 0.060 |
Why?
|
| Rectum | 1 | 2007 | 480 | 0.060 |
Why?
|
| Neoplasms | 4 | 2018 | 15951 | 0.060 |
Why?
|
| Urinary Bladder | 1 | 2007 | 592 | 0.060 |
Why?
|
| Organs at Risk | 2 | 2018 | 559 | 0.060 |
Why?
|
| Polymethyl Methacrylate | 1 | 2023 | 41 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2012 | 7788 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2005 | 266 | 0.050 |
Why?
|
| Ions | 1 | 2022 | 57 | 0.050 |
Why?
|
| Patients | 1 | 2005 | 247 | 0.050 |
Why?
|
| Boron | 1 | 2021 | 12 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2022 | 160 | 0.050 |
Why?
|
| Boron Compounds | 1 | 2022 | 72 | 0.050 |
Why?
|
| Cell Survival | 2 | 2019 | 3058 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 12041 | 0.050 |
Why?
|
| Male | 12 | 2022 | 128479 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5582 | 0.040 |
Why?
|
| Risk Factors | 3 | 2005 | 17850 | 0.040 |
Why?
|
| Rad51 Recombinase | 1 | 2019 | 125 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 14885 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 541 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 327 | 0.030 |
Why?
|
| Animals | 1 | 2021 | 61350 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2019 | 825 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 639 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 983 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 1306 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 1092 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 2313 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 4148 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 1512 | 0.020 |
Why?
|
| Time Factors | 2 | 2019 | 12974 | 0.020 |
Why?
|
| Calibration | 1 | 2012 | 346 | 0.020 |
Why?
|
| Melanoma | 1 | 2008 | 5596 | 0.020 |
Why?
|
| Systems Integration | 1 | 2010 | 68 | 0.020 |
Why?
|
| Physical Phenomena | 1 | 2007 | 19 | 0.020 |
Why?
|
| Texas | 2 | 2010 | 6445 | 0.020 |
Why?
|
| Physics | 1 | 2007 | 44 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2008 | 144 | 0.020 |
Why?
|
| Electrons | 1 | 2008 | 188 | 0.020 |
Why?
|
| Head | 1 | 2008 | 248 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 920 | 0.020 |
Why?
|
| Gold | 1 | 2007 | 268 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2007 | 248 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 1929 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 1998 | 0.010 |
Why?
|
| Female | 4 | 2017 | 148873 | 0.010 |
Why?
|
| Ethylamines | 1 | 2002 | 3 | 0.010 |
Why?
|
| Radiation Oncology | 1 | 2007 | 557 | 0.010 |
Why?
|
| Pressure | 1 | 2002 | 186 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 13407 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 14000 | 0.010 |
Why?
|
| Microscopy | 1 | 2002 | 189 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 7921 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 17076 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 15922 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 31113 | 0.010 |
Why?
|
| United States | 1 | 2013 | 15817 | 0.010 |
Why?
|
| Child | 1 | 2016 | 30563 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 73601 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 82042 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 90517 | 0.010 |
Why?
|